Lots of exciting insights with oncology manufacturer benchmarking rating on customer experience along with insights on access challenges (e.g., maximizer/accumulator, IRA, AFP) impact on HCPs, field utilization, advances with AI, patient attrition drivers, etc. The study is the most comprehensive of its kind and is bringing the customer voice to strategic decision-making! (see https://lnkd.in/edZbfiUE for more info) #pharma #CustomerExperience #Benchmarking #PURE

Navigating the complex oncology landscape of market access? Envision - your strategic compass for recently approved oncology assets.     Our forward-looking evaluations provide invaluable insights months ahead of formal HTA decisions, bridging the gap between regulatory approval and market viability. Make informed decisions with major downstream implications for your product's success.    Watch our interview with Executive Director Tijana Ignjatovic as she discusses how with Envision you can access forward-looking evaluations and comprehensive strategic direction for market access viability after a product has received positive EMA or FDA guidance.   #MarketAccess #Oncology #StrategicPlanning 

Lead Oncology Billing with Predictive Analytics Oncology billing is complex, but it doesn’t have to be. At iMagnum Healthcare Solutions, we use predictive analytics to foresee potential challenges and proactively address them. Our focus is on accuracy and efficiency, so your practice remains financially strong while you focus on patient care. Interested in optimizing your oncology billing? Learn more: [Oncology Billing](https://lnkd.in/gCgEbRXK) #OncologyBilling #PredictiveAnalytics #HealthcareSolutions #ClaimAccuracy #HealthcareTechnology

Mark your calendars now for this relevant and interesting webinar!

ESOP GLOBAL E-Health WG Telepharmacy: Revolutionizing Oncology Care! Oncology pharmacists are now more accessible than ever! With telepharmacy, cancer patients can receive specialized pharmaceutical care from the comfort of their homes, improving treatment adherence, managing side effects, and ensuring personalized care every step of the way. Whether it's monitoring medications, adjusting dosages, or providing remote consultations, telepharmacy is transforming how we care for oncology patients. ✨ Let’s empower more lives with remote care! #ehealth_wg #ESOP_global #Telepharmacy #OncologyPharmacy #CancerCare #DigitalHealth #PatientCare #Pharmacists #ESOPGlobal Question for Discussion: How do you think telepharmacy can further enhance cancer care in your community? Share your thoughts!

Look around 👀 You likely see some people talking about interesting things they want to do in their careers and others who are actually doing interesting things The difference? Some people take action and others don’t. Have you noticed that time seems to move faster as you get older? It’s freakishly easy to let a few, or even many, years slip by without doing the things you say you want to do. This is the trap of becoming comfortable. You find a rhythm that works and you lean into it more and more until you’re in so deep it takes a gigantic effort to swim out. Stop letting time slip by you like there is an endless supply of it - there are no “perfect” moments, there is only right now --- 📌 When you’re ready to build your oncology knowledge like you say you want to, I can help you. Start by getting the Oncology Insights Newsletter that fosters your continuous growth in oncology pharmacy practice https://lnkd.in/gYyirSen I’m the Kelley in KelleyCPharmD 👋 and I help pharmacists learn the complex world of oncology #LearnOncology #Pharmacists #OncologyPharmacists #Oncology

🔊 Latest article! 💊Patient-centred oncology: transforming drug development As deeper understanding of disease makes the development and commercialisation of oncology drugs more complex, developers are under more pressure than ever to deliver value-based treatments. In this article, Rebecca Goldstein, Senior Principal, Strategic Consulting at Envision Pharma Group, explores anchoring a programme to patient experience as a solution. Click here to read more! 👉 https://bit.ly/3WRG70z #oncology #drugdevelopment #therapeutics

📣Parexel weighs in on the FDA's new Oncology Guidance. 📣   Mwango Kashoki MD MPH, SVP and Global Head of Regulatory Strategy, recently wrapped up a compelling interview series with Andy Studna of Applied Clinical Trials Magazine. Here’s a quick recap:   🎥 1. Initial Reactions: Thoughts on the FDA's latest guidance on multiregional clinical trials in oncology and its potential to transform the landscape. https://lnkd.in/eyEh6rfb 🌍 2. Driving Diversity: How by promoting more diverse trial site locations and patient populations, there’s potential for more inclusive oncology studies. https://lnkd.in/e7yQSiTU 📅 3. Planning Ahead: Why sponsors will need to be even more strategic in planning their oncology trials to align with the new guidelines. https://lnkd.in/ek3xzckS ⚖️ 4. Regulatory Challenges: On the complexities of meeting multiple regulatory requirements across different regions. https://lnkd.in/eHg927yd 🔍 5. Better Trials Ahead: How this guidance could lead to better design in oncology trials and ultimately greater diversity in patient representation. https://lnkd.in/eMm-uym8 What are your thoughts on the new guidance? Share in the comments below!  #ClinicalTrials #Oncology #DiversityInTrials #FDAGuidance #Regulatory

📅 Save the Date: September 12, 2024 Join us for an informative webinar on "Medicare Coverage Analysis in Oncology Trials" presented by Nitya Maddodi. Gain valuable insights into Medicare Coverage Analysis and learn how to improve your oncology #ClinicalTrials. Don't miss this opportunity—reserve your spot today. #ClinicalResearch #Oncology #Advarra

Join NCODA and SAVE THE DATE for the 2024 Oncology Institute - an initiative aimed at fostering a stronger collaboration between medically integrated oncology practices, industry partners, and NCODA.   Powered by ZS, the 2024 meeting focus topics include: - Equitable Care Delivery - Clinical Trial Engagement - Drug Distribution Models - Patient Services & Support - Social Determinants of Health - Data & Insights   Participants of the meeting will be able to: - Learn how industry can best engage with providers to drive equitable outcomes for patients - Engage with key stakeholders dedicated to enhancing the patient experience from diagnosis to survivorship - Showcase how your organization is partnering to drive equitable care delivery - Join pivotal conversations about patient-centric services and support systems - Partner in discussions to shape the future of oncology drug distribution focused on patient access to innovative treatments - Contribute to the advancement of provider and patient education in oncology   REGISTRATION OPENING SOON! Learn more at the link below: https://lnkd.in/diSu8Ce